Latest healthtech and biotech deals
The largest from last week:
🇨🇳 Edge Medical Robotics raised $200M in Series B from Temasek and Sequoia and others. The company transforms smart surgery through new-generation robotic systems and solutions. Early this year, China Food and Drug Administration (CFDA) approved Edge Medical’s single-port surgical robot, and it is applying for clinical trial registration.
🇫🇷 Owkin became a unicorn by raising $180M from Sanofi at $1.0B valuation. The Parisian AI startup runs a virtual lab (research platform, and a portfolio of AI models and solutions) where clinicians, pharma companies and academics can access anonymized data sets and models. Sanofi will use Owkin’s technology to find new biomarkers and therapeutic targets, build prognostic models, and predict response to treatment from multimodal patient data.
🇫🇷 Lifen, operating system for healthcare infrastructure, raised $58M. The startup built a document platform that works with several electronic messaging protocols designed for medical records. It makes it much easier to go paperless and send reports automatically. Here 100+ European B2B healthtech startups developing solutions for hospitals and medical professionals.
🇮🇪 Nuritas raised $45M in Series B. Nuritas’ flagship product is its database of plant-based peptides, which have been discovered through its proprietary AI-powered platform, Peptide Finder.
Other notable deals from around the globe:
🇺🇸 AppliedVR, VR digital therapeutic, raised $36M in Series B. AppliedVR is building an unparalleled body of evidence that demonstrates its immersive therapeutics are effective and usable for patients, scalable for providers and viable for payer reimbursement.
🇺🇸 Rad AI raised $25M in Series A to transform radiology workflow by harnessing the power of AI.
Read up on all the latest health deals in Dealroom.co
